Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information.

Feeley, Linda P

Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information. [electronic resource] - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Apr 2014 - 554-61 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1530-0285

10.1038/modpathol.2013.153 doi


Breast Neoplasms--chemistry
Carcinoma--chemistry
Chi-Square Distribution
Diagnosis, Differential
Disease-Free Survival
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Ki-67 Antigen--analysis
Multivariate Analysis
Neoplasm Invasiveness
Ontario
Predictive Value of Tests
Proportional Hazards Models
Prospective Studies
Receptor, ErbB-2--analysis
Receptors, Estrogen--analysis
Receptors, Progesterone--analysis
Risk Factors
Time Factors
Tumor Suppressor Protein p53--analysis